Company / PP&E per Share
Astria Therapeutics, Inc. PP&E per Share History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2018
5-year range
-
FY2015-FY2018
Trend
-92.5%
vs FY2017
Sector context
#155 of 191
Health Care
What the data says
Astria Therapeutics, Inc.'s pp&e per share of $0.01 is lower than 81% of companies in the Health Care sector (FY2018). Declined from $0.03 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2018 with a 3-year CAGR of -43.9%.
Declined from $0.03 to $0.01 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -43.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 191This company $0.01 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2018, pp&e per share decreased 92.5% year-over-year.
- Ranks #155 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.01 | -92.5% |
| FY2017 | $0.15 | +323.0% |
| FY2016 | $0.03 | -44.2% |
| FY2015 | $0.06 | -90.8% |
As of FY2018 · SEC 10-K · Updated Feb 28, 2026